Glucose sensor and uses thereof
First Claim
1. An isolated or purified recombinant human glucokinase polypeptide having decreased catalytic activity but a substantially identical ability to bind glucose relative to a corresponding wild-type human glucokinase. polypeptide, wherein said corresponding wild-type human glucokinase polypeptide has an amino acid sequence as set forth in GenBank Accession No. AAA52562, GenBank Accession No. AAA51824, GenBank Accession No. NP—
- 000153, GenBank Accession No. P35557;
GenBank Accession No. AAB97681, GenBank Accession No. NP—
277042;
GenBank Accession No. AAB97682, GenBank Accession No. NP—
277043;
GenBank Accession No. AAB59563 or SEQ ID NO;
2, or is encoded by a nucleotide sequence as set forth in GenBank Accession No. M90299, GenBank Accession No. M88011, GenBank Accession No. NM—
000162, GenBank Accession No. NM—
033507;
GenBank Accession No. NM—
033508;
GenBank Accession No. M69051, GenBank Accession No. AH005826 or SEQ ID NO;
1;
said recombinant human glucokinase polypeptide comprises an amino acid sequence that differs from the sequence of the corresponding wild-type human glucokinase polypeptide by a mutation at an amino acid residue corresponding to Asp 78, Ser 151, Asp 205, Arg 85, Lys 169, Gly 81, Lys 169, Thr 82, Asn83, Thr228, Ser 411, Lys 296, Ser 336, Thr332, Glu 290, Thr268, Glu256, Asn204, Asn231 or Lys269 of said corresponding wild-type human glucokinase polypeptide; and
said recombinant human glucokinase polypeptide further comprises at least one affinity tag or reactive group for immobilizing said recombinant human glucokinase polypeptide onto a solid surface.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides a glucokinase protein in which the catalytic activity has been disabled in order to enable its use as a glucose sensor. The catalytically disabled glucokinase protein can be used as the glucose sensor in hand-held glucose monitors and in implantable glucose monitoring devices. The glucose sensor can also be incorporated into biomedical devices for the continuous monitoring of glucose and administration of insulin.
-
Citations
27 Claims
-
1. An isolated or purified recombinant human glucokinase polypeptide having decreased catalytic activity but a substantially identical ability to bind glucose relative to a corresponding wild-type human glucokinase. polypeptide, wherein
said corresponding wild-type human glucokinase polypeptide has an amino acid sequence as set forth in GenBank Accession No. AAA52562, GenBank Accession No. AAA51824, GenBank Accession No. NP— - 000153, GenBank Accession No. P35557;
GenBank Accession No. AAB97681, GenBank Accession No. NP—
277042;
GenBank Accession No. AAB97682, GenBank Accession No. NP—
277043;
GenBank Accession No. AAB59563 or SEQ ID NO;
2, or is encoded by a nucleotide sequence as set forth in GenBank Accession No. M90299, GenBank Accession No. M88011, GenBank Accession No. NM—
000162, GenBank Accession No. NM—
033507;
GenBank Accession No. NM—
033508;
GenBank Accession No. M69051, GenBank Accession No. AH005826 or SEQ ID NO;
1;
said recombinant human glucokinase polypeptide comprises an amino acid sequence that differs from the sequence of the corresponding wild-type human glucokinase polypeptide by a mutation at an amino acid residue corresponding to Asp 78, Ser 151, Asp 205, Arg 85, Lys 169, Gly 81, Lys 169, Thr 82, Asn83, Thr228, Ser 411, Lys 296, Ser 336, Thr332, Glu 290, Thr268, Glu256, Asn204, Asn231 or Lys269 of said corresponding wild-type human glucokinase polypeptide; and
said recombinant human glucokinase polypeptide further comprises at least one affinity tag or reactive group for immobilizing said recombinant human glucokinase polypeptide onto a solid surface. - View Dependent Claims (2, 3, 4, 5, 6, 7, 14, 16)
- 000153, GenBank Accession No. P35557;
-
8. An isolated or purified recombinant human glucokinase polypeptide having decreased catalytic activity but a substantially identical ability to bind glucose relative to a corresponding wild-type human glucokinase polypeptide, wherein:
-
said corresponding wild-type human glucokinase polypeptide has an amino acid sequence as set forth in GenBank Accession No. AAA52562, GenBank Accession No. AAA51824, GenBank Accession No. NP—
000153, GenBank Accession No. P35557;
GenBank Accession No. AAB97681, GenBank Accession No. NP—
277042;
GenBank Accession No. AAB97682, GenBank Accession No. NP—
277043;
GenBank Accession No. AAB59563 or SEQ ID NO;
2, or is encoded by a nucleotide sequence as set forth in GenBank Accession No. M90299, GenBank Accession No. M88011, GenBank Accession No. NM—
000162, GenBank Accession No. NM—
033507, GenBank Accession No. NM—
033508;
GenBank Accession No. M69051;
GenBank Accession No. AH005826 or SEQ ID NO;
1;
said recombinant human glucokinase polypeptide comprises an amino acid sequence that differs from the sequence of the corresponding wild-type human glucokinase polypeptide by a mutation at the amino acid residue corresponding to Asp 205 of said corresponding wild-type human glucokinase polypeptide; and
said recombinant human glucokinase polypeptide further comprises at least one affinity tag or reactive group for immobilizing said recombinant human glucokinase polypeptide onto a solid surface. - View Dependent Claims (9, 10, 11, 12, 13, 15, 17)
-
-
18. An isolated or purified recombinant human glucokinase polypeptide having decreased catalytic activity but a substantially identical ability to bind glucose relative to a corresponding wild-type human glucokinase. polypeptide, wherein:
-
said corresponding wild-type human glucokinase polypeptide has an amino acid sequence as set forth in GenBank Accession No. AAA52562, GenBank Accession No. AAA51824, GenBank Accession No. NP—
000153, GenBank Accession No. P35557;
GenBank Accession No. AAB97681, GenBank Accession No. NP—
277042;
GenBank Accession No. AAB97682, GenBank Accession No. NP—
277043;
GenBank Accession No. AAB59563 or SEQ ID NO;
2, or is encoded by a nucleotide sequence as set forth in GenBank Accession No. M90299, GenBank Accession No. M88011, GenBank Accession No. NM—
000162, GenBank Accession No. NM—
033507;
GenBank Accession No. NM—
033508;
GenBank Accession No. M69051, GenBank Accession No. AH005826 or SEQ ID NO;
1;
said recombinant human glucokinase polypeptide comprises an amino acid sequence that differs from the sequence of the corresponding wild-type human glucokinase polypeptide by a mutation at the amino acid residue corresponding to Ser336 of said corresponding wild-type human glucokinase polypeptide; and
said recombinant human glucokinase polypeptide further comprises at least one affinity tag or reactive group for immobilizing said recombinant human glucokinase polypeptide onto a solid surface. - View Dependent Claims (19, 20, 21, 22, 23, 24, 25, 26, 27)
-
Specification